In Other News

• Epigenetic Profiling Assay Stratifies AML and Predicts Treatment Response

• Genetic Risk Score Supports Diagnosis and Prognosis in Idiopathic Pulmonary Fibrosis

• New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

• Extracellular Vesicle Marker Identifies Early Lung Adenocarcinoma and Predicts Recurrence

• CE-Marked Blood Assay Automates Tuberculosis Infection Testing

• New AI Test Delivers Rapid Breast Cancer Recurrence Predictions

• Training Device Improves Accuracy of Pooled Molecular Diagnostics

• New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

• Newly CE-Marked Blood Assay Automates Tuberculosis Infection Testing

• AI Reveals Immune Response Biomarkers Linked to Ebola Survival

• Blood Test Brings Alzheimer’s Biomarker Assessment to Routine Labs

• AI Reveals Immune Response Biomarkers Linked to Ebola Survival

• AI Decision Support System Guides Treatment Selection for Complex Blood Cancers

• WHO Adds First Bundibugyo Ebola Molecular Test to Emergency Use Listing

• Study Supports Earlier Genetic Testing for Hereditary Breast and Ovarian Cancer

• Rapid Brush Biopsy Test Detects Oral Cancer in One Hour

• Noninvasive Biomarkers Advance Colorectal Cancer Risk Assessment

• Genomic Surveillance Algorithm Improves Early Detection of Emerging Variants

• AI-Driven Blood Test Enhances Early Detection of Multiple Cancers

• Noninvasive Biomarkers Advance Colorectal Cancer Risk Assessment

• Blood Test Helps Guide Post-Surgical Treatment in Metastatic Colorectal Cancer

• EBV Status Helps Predict Survival in Primary CNS Lymphoma

• New CE-Certified Software Advances Whole-Genome Cancer Testing